TY - JOUR
T1 - Developing trustworthy recommendations as part of an urgent response (1–2 weeks): a GRADE concept paper
AU - Akl, Elie A.
AU - Morgan, Rebecca L.
AU - Rooney, Andrew A.
AU - Beverly, Brandiese
AU - Katikireddi, Srinivasa Vittal
AU - Agarwal, Arnav
AU - Alper, Brian S.
AU - Alva-Diaz, Carlos
AU - Amato, Laura
AU - Ansari, Mohammed T.
AU - Brozek, Jan
AU - Chu, Derek K.
AU - Dahm, Philipp
AU - Darzi, Andrea J.
AU - Falavigna, Maicon
AU - Gartlehner, Gerald
AU - Pardo-Hernandez, Hector
AU - King, Valerie
AU - Klugarová, Jitka
AU - Langendam, M. W. Miranda
AU - Lockwood, Craig
AU - Mammen, Manoj
AU - Mathioudakis, Alexander G.
AU - McCaul, Michael
AU - Meerpohl, Joerg J.
AU - Minozzi, Silvia
AU - Mustafa, Reem A.
AU - Nonino, Francesco
AU - Piggott, Thomas
AU - Qaseem, Amir
AU - Riva, John
AU - Rodin, Rachel
AU - Sekercioglu, Nigar
AU - Skoetz, Nicole
AU - Traversy, Gregory
AU - Thayer, Kris
AU - Schünemann, Holger
N1 - Funding Information: Alexander G. Mathioudakis is supported by the NIHR Manchester Biomedical Research Centre (BRC), United Kindgom. Srinivasa V. Katikireddi acknowledges funding from an NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_12017/13), United Kindgom, and the Scottish Government Chief Scientist Office (SPHSU13), United Kindgom. Derek K. Chu is a CAAIF-CSACI-AllerGen Emerging Clinician-Scientist Research Fellow, supported by the Canadian Allergy, Asthma and Immunology Foundation (CAAIF), Canada, the Canadian Society of Allergy and Clinical Immunology (CSACI), Canada, and AllerGen NCE Inc. (the Allergy, Genes and Environment Network supported by the Networks of Centres of Excellence), Canada. Funding Information: Alexander G. Mathioudakis is supported by the NIHR Manchester Biomedical Research Centre ( BRC ), United Kindgom. Srinivasa V. Katikireddi acknowledges funding from an NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_12017/13), United Kindgom, and the Scottish Government Chief Scientist Office (SPHSU13), United Kindgom. Derek K. Chu is a CAAIF-CSACI- AllerGen Emerging Clinician-Scientist Research Fellow, supported by the Canadian Allergy, Asthma and Immunology Foundation ( CAAIF ), Canada, the Canadian Society of Allergy and Clinical Immunology (CSACI), Canada, and AllerGen NCE Inc. (the Allergy, Genes and Environment Network supported by the Networks of Centres of Excellence), Canada. Publisher Copyright: © 2020 The Author(s) Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Objectives: The aim of this study is to propose an approach for developing trustworthy recommendations as part of urgent responses (1–2 week) in the clinical, public health, and health systems fields. Study Design and Setting: We conducted a review of the literature, outlined a draft approach, refined the concept through iterative discussions, a workshop by the Grading of Recommendations Assessment, Development and Evaluation Rapid Guidelines project group, and obtained feedback from the larger Grading of Recommendations Assessment, Development and Evaluation working group. Results: A request for developing recommendations within 2 week is the usual trigger for an urgent response. Although the approach builds on the general principles of trustworthy guideline development, we highlight the following steps: (1) assess the level of urgency; (2) assess feasibility; (3) set up the organizational logistics; (4) specify the question(s); (5) collect the information needed; (6) assess the adequacy of identified information; (7) develop the recommendations using one of the 4 potential approaches: adopt existing recommendations, adapt existing recommendations, develop new recommendations using existing adequate systematic review, or develop new recommendations using expert panel input; and (8) consider an updating plan. Conclusion: An urgent response for developing recommendations requires building a cohesive, skilled, and highly motivated multidisciplinary team with the necessary clinical, scientific, and methodological expertise; adapting to shifting needs; complying with the principles of transparency; and properly managing conflicts of interest.
AB - Objectives: The aim of this study is to propose an approach for developing trustworthy recommendations as part of urgent responses (1–2 week) in the clinical, public health, and health systems fields. Study Design and Setting: We conducted a review of the literature, outlined a draft approach, refined the concept through iterative discussions, a workshop by the Grading of Recommendations Assessment, Development and Evaluation Rapid Guidelines project group, and obtained feedback from the larger Grading of Recommendations Assessment, Development and Evaluation working group. Results: A request for developing recommendations within 2 week is the usual trigger for an urgent response. Although the approach builds on the general principles of trustworthy guideline development, we highlight the following steps: (1) assess the level of urgency; (2) assess feasibility; (3) set up the organizational logistics; (4) specify the question(s); (5) collect the information needed; (6) assess the adequacy of identified information; (7) develop the recommendations using one of the 4 potential approaches: adopt existing recommendations, adapt existing recommendations, develop new recommendations using existing adequate systematic review, or develop new recommendations using expert panel input; and (8) consider an updating plan. Conclusion: An urgent response for developing recommendations requires building a cohesive, skilled, and highly motivated multidisciplinary team with the necessary clinical, scientific, and methodological expertise; adapting to shifting needs; complying with the principles of transparency; and properly managing conflicts of interest.
KW - GRADE
KW - Pandemic
KW - Trustworthy guideline
KW - Urgent recommendation
UR - http://www.scopus.com/inward/record.url?scp=85093955598&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.jclinepi.2020.09.037
DO - https://doi.org/10.1016/j.jclinepi.2020.09.037
M3 - Article
C2 - 33010401
SN - 0895-4356
VL - 129
SP - 1
EP - 11
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
ER -